FDA Adverse Event Injury Summary report: N

EVOLUT R TRANSCATHETER AORTIC VALVE

MDR report key: 7564169 · Received June 3, 2018

Report

Report Number
2025587-2018-01360
Event Type
Injury
Date Received
June 3, 2018
Date of Event
March 8, 2018
Report Date
June 3, 2018
Manufacturer
MEDTRONIC HEART VALVES DIVISION
Product Code
NPT
PMA / PMN Number
P130021
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CT, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

CITATION: SHAH A. CLINICAL OUTCOMES FOR MEDTRONIC EVOLUT-R VERSUS CORE VALVE TRANSCATHETER AORTIC VALVE IMPLANTATION JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY MAR; 71(11): SUPPL A1134 EPUB 2018 MAR 8 DOI 10.1016/S0735-1097(18)31675-9 EARLIEST DATE OF PUBLISH USED FOR EVENT DATE. NO UNIQUE DEVICE IDENTIFIER (SERIAL/LOT) NUMBERS WERE PROVIDED; WITHOUT THIS INFORMATION IT COULD NOT BE DETERMINED WHETHER THESE OBSERVATIONS HAVE BEEN PREVIOUSLY REPORTED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

MEDTRONIC RECEIVED INFORMATION VIA POSTER PRESENTATION ON META-ANALYSIS REGARDING CLINICAL OUTCOMES FOR MEDTRONIC EVOLUT-R VERSUS CORE VALVE TRANSCATHETER AORTIC VALVE IMPLANTATION. ALL DATA WERE COLLECTED FROM MULTIPLE STUDIES UNTIL FEBRUARY 2017. THE OVERALL STUDY POPULATION INCLUDED 9,737 PATIENTS, OF WHICH, 6,820 PATIENTS WERE IMPLANTED WITH MEDTRONIC COREVALVE® AND 2,917 PATIENTS WERE IMPLANTED WITH MEDTRONIC EVOLUT R PROSTHESIS (SERIAL NUMBERS NOT PROVIDED). AMONG ALL PATIENTS ADVERSE EVENTS INCLUDED: CEREBRAL VASCULAR ACCIDENT (CVA), PERMANENT PACEMAKER AND VASCULAR COMPLICATIONS. BASED ON THE AVAILABLE INFORMATION, A DIRECT CORRELATION WAS LIKELY BETWEEN THE OBSERVED ADVERSE EVENTS AND MEDTRONIC PRODUCT. NO ADDITIONAL ADVERSE PATIENT EFFECTS OR PRODUCT PERFORMANCE PROBLEMS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
406322 EVOLUT R TRANSCATHETER AORTIC VALVE AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED NPT MEDTRONIC HEART VALVES DIVISION EVOLUTR-23

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention